Figure 2From: Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference The 5-year overall survival for all enrolled patients. The 5-year overall survival was 37.4% (95% CI, 30.5% to 44.3%) for the D1 group and 48.7% (95% CI, 41.6% to 55.8%) for the D3 group (log-rank p = 0.027).Back to article page